An evaluation of economics and acceptability of screening for <i>Chlamydia trachomatis</i> infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK

Abstract

A single episode of screening for C. trachomatis does not result in net cost savings. Currently recommended strategies of screening for C. trachomatis in women under 25 years of age in abortion clinics are supported by our data on prevalence and acceptability. These data also suggest that hospital-based screening strategies should be further extended to include younger women attending antenatal clinics and all women of reproductive age attending colposcopy clinics.